Overview

Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study was to compare the antiemetic efficacy of aprepitant plus palonosetron versus aprepitant plus ramosetron in high risk patients undergoing laparoscopic cholecystectomy.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kyungpook National University
Kyungpook National University Hospital
Treatments:
Aprepitant
Fosaprepitant
Palonosetron
Ramosetron
Criteria
Inclusion Criteria:

- Non smoking, female patients, scheduled for laparoscopic cholecystectomy

Exclusion Criteria:

- Patients with gastrointestinal disorder,

- Patients with allergies to any study medication,

- Patients who had received any sedatives, opioid, steroid or antiemetics within 24 h
before surgery